Tags
clinical trials
Latest Tag News
-
Patient Under Ocrevus Trial with Relapsing-Remitting Multiple Sclerosis Feels Great Again [VIDEO]
By Alleah Kiamco | Apr 13, 2017 09:23 AM EDTOcrevus antibody for the treatment of Relapsing-Remitting Multiple Sclerosis (RMS). Patient taking partin the clinical trial shares that she's feeling great again with the ocrelizumab infusion.
-
Implants on Paralyzed Man, Groundbreaking Study For Complete Paralysis Patients [VIDEO]
By Alleah Kiamco | Apr 10, 2017 11:39 AM EDTImplants on paralyzed man for eight years allowed him to send signals from his brain to his arm and shoulders.
-
Fountain Of Youth: Startup Company Infuses The Body Full Of Young Blood
By Angela Laguipo | Jan 17, 2017 08:10 AM ESTAmbrosia, a tech startup company, is offering a clinical trial to see if transfusing young blood to older people will aid in slowing down aging.
-
Breast Cancer Update: Clinical Trials For Possible Treatment For Triple Negative Breast Cancer Underway
By Minnow Blythe | Jan 09, 2017 10:36 PM ESTCancer researchers are looking into a possible effective treatment for Triple Negative Breast Cancer.
-
Should 3-Person Embryos Go Alive?
By R. Siva Kumar | Feb 04, 2016 12:01 PM ESTThe U.S. National Academy of Medicine asks the FDA to approve clinical trials for three-person embryos.
-
Vitamin D May Regulate Hyperactive Immune Response In Multiple Sclerosis Patients
By R. Siva Kumar | Jan 02, 2016 08:32 PM ESTHigh doses of Vitamin D supplements might reduce the hyperactive immune response in patients of multiple sclerosis.
-
Minorities Continue to be Underrepresented in Clinical Trials
By Cheri Cheng | Mar 22, 2014 10:26 AM EDTA new report found that minorities only make up around two percent of all clinical trials.
-
FDA Reports More Info Needed on “Female Viagra”
By Cheri Cheng | Feb 12, 2014 11:28 AM ESTThe FDA has asked Sprout Pharmaceuticals to perform more trials for its female sexual libido drug.
-
Study Questions FDA Approval Time
By Cheri Cheng | Oct 29, 2013 02:03 PM EDTA new study published in JAMA found that in 2008, eight drugs where approved faster due to expedited review.
-
Government Shutdown Hurts NIH Clinical Trials
By Cheri Cheng | Oct 02, 2013 09:23 AM EDTThe NIH reported that for every week the government is shut down, nearly 200 patients will be turned away from new clinical trials.
